Roche Sylvant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Sylvant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Sylvant Today - Breaking & Trending Today

China 2022 National Reimbursement Drug List Drug Pricing

Published: February 28, 2023

China National Healthcare Security Administration NHSA published 2022 National Reimbursement Drug List 2022 NRDL, implementing comparable level of pricing discounts to those seen in 2021. Out of 147 drugs negotiated, 121 were successfully added to 2022 NRDL, including 91 exclusive.

Source: natlawreview.com

Related Topics:

Novartis KesimptaAbbvie VenclextaBrii Bioscience AmubarvimabTakeda VprivTakeda AlunbrigtmRoche SylvantJunsi BiosciencesTakeda TakhzyroNovartis ZolgensmaHenlius SerplulimabTakeda AlglucosidaseRoche RisdiplamCstone PharmaceuticalsNational Health CommissionChina National Healthcare Security AdministrationNational Reimbursement Drug ListNational Medical Products AdministrationNational Healthcare Security AdministrationInsurance Resource Spending At National LevelNational Medical InsuranceReimbursement Drug ListEffective DateConsistent Price CutMedical Insurance Resource SpendingGenuine Biotech